FetoLife Science logo

FetoLife Science

FetoLife is a digital women's health company with a focus on pregnancy health risk.

1 employees · est. 2020 · Wien, Austria

VS
WeFast App logo

WeFast App

WeFast: Intermittent fasting app for women

26 employees · est. 2021

FetoLife Science is the older company (2020 vs 2021); WeFast App is the larger of the two.

Side-by-Side Comparison

FetoLife Science WeFast App
Founded
2020 older 2021
Headquarters
Wien, Austria Not tracked yet
Employees
1 26 larger
Industry
Digital Health, Health Care, Health and Wellness Digital Health, Fintech, Health Care
Funding Stage
Seed Seed
Total Funding
$1.00M Not tracked yet
Funding Rounds
1 1
Services
Not tracked yet Intermittent fasting guidance, Personalized diet plans, Health tracking app
Target Customers
Not tracked yet Women seeking weight loss solutions, Individuals interested in intermittent fasting, Health-conscious users
Taxonomy
Pregnancy App, Women's Health, Self-management Tools, Personalized Health Insights, Mobile Health, Digital Health Tools, Empowerment, Healthcare Access, Pregnancy Care, Maternal Health, User-friendly, Well-being, Health Resources, Remote Healthcare Intermittent Fasting, Women's Health, Health And Fitness App, Health Community, Nutrition Expertise, Digital Health, Healthcare Professional Interaction, Insurance Forms Management, Pharmaceutical Support, Secure Data Transmission, Patient Care Acceleration, API Integration, Healthcare Digitalization, Telehealth Solutions
Website
fetolife.com wefast.care
FetoLife Science logo

About FetoLife Science

FetoLife Science is a pioneering digital women's health startup, founded in 2019 and headquartered in Austria. The company's slogan, "FetoLife is a digital women's health company with a focus on pregnancy health risk," encapsulates its core focus. FetoLife has developed a first-of-its-kind pregnancy...

WeFast App logo

About WeFast App

WeFast App, with its tagline "WeFast: Intermittent fasting app for women", focuses on enhancing women's health through specialized intermittent fasting solutions. Established in 2021, WeFast has rapidly emerged as a community-oriented platform, creating a supportive environment for women to share th...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at FetoLife Science and WeFast App — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at FetoLife Science and WeFast App — by email.

Frequently Asked Questions

FetoLife Science — FetoLife is a digital women's health company with a focus on pregnancy health risk.. WeFast App — WeFast: Intermittent fasting app for women. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
FetoLife Science has raised $1.00M while WeFast App has raised undisclosed funding.
FetoLife Science and WeFast App operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare FetoLife Science with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy